L-theanine is an amino acid found naturally in tea leaves and in some mushrooms. It is sold as a stand alone capsule and as an ingredient in calm focus blends, sleep gummies, and some energy drink style powders that pair it with caffeine. Employers and job candidates sometimes ask whether a tea derived supplement like this can affect a pre employment or random drug screen. The short answer is that L-theanine is not a controlled substance, it is not an analyte on any standard drug test panel, and there is no credible published evidence that it causes a false positive on a workplace screen. This article explains what L-theanine is, how workplace drug panels are built, why an amino acid from tea is not part of that design, and what to do if a result still needs review.
What L-theanine actually is
L-theanine (sometimes written theanine) is a non protein amino acid most concentrated in the leaves of the tea plant, Camellia sinensis, which is the source plant for green, black, white, and oolong tea. It also occurs in small amounts in certain mushroom species. Dietary supplement manufacturers extract or synthesize it and sell it in capsules, powders, and drink mixes, usually marketed for relaxation without drowsiness, sleep support, or focus when combined with caffeine. The National Institutes of Health's Drugs and Lactation Database (LactMed) entry on theanine, hosted on the NIH Bookshelf, catalogs theanine as a dietary supplement derived from tea and describes its chemical identity and the limited human data available on its effects, which is a useful starting point for understanding what is and is not established about it.
L-theanine is not a pharmaceutical drug. The Food and Drug Administration does not approve dietary supplement ingredients the way it approves prescription drugs; supplement ingredients instead move through notification pathways such as New Dietary Ingredient notifications or Generally Recognized as Safe (GRAS) determinations, and manufacturers have submitted GRAS notices for specific L-theanine preparations used as food and beverage ingredients. The FDA's Generally Recognized as Safe (GRAS) program page explains how that notification process works and what a GRAS status does and does not mean. A GRAS notice is not a marketing claim and it does not mean the FDA has evaluated or approved the ingredient as safe for every use; it also has nothing to do with workplace drug testing, since GRAS review only concerns food safety, not analyte lists on a drug panel.
How workplace drug test panels are actually built
Standard drug test cups, dip cards, and oral fluid tests are built around a fixed list of target analytes, most of them drawn from the classes identified decades ago by federal workplace testing guidance and still used across most commercial 5 panel, 10 panel, and expanded panel configurations. The National Institute on Drug Abuse, part of NIH, maintains a drug testing overview describing how these panels screen for specific drug classes such as amphetamines, cocaine metabolites, opioids, cannabinoids, and PCP, among others depending on the panel size. The Substance Abuse and Mental Health Services Administration (SAMHSA) sets the federal Mandatory Guidelines that many regulated and voluntary workplace programs follow, and its Drug-Free Workplace Programs resource outlines the certified laboratory process, the use of immunoassay screening followed by confirmation testing, and the role of the medical review officer in reviewing any non negative result.
An immunoassay screen works by using antibodies designed to bind to a specific drug or drug metabolite, or to molecules that are chemically similar enough to cross react. Cutoff concentrations and antibody targets are chosen and validated by the panel manufacturer and by federal guidance for the specific substances on that panel, not for every compound a person might consume. L-theanine is an amino acid with a different structure than the opioids, amphetamines, cannabinoids, benzodiazepines, or other classes targeted by standard immunoassays. There is no published, peer reviewed evidence of cross reactivity between L-theanine and any standard workplace drug test antibody, and no federal guidance document lists amino acid supplements like L-theanine among the substances workplace panels are designed to detect.
| Panel component | What it targets | Does L-theanine relate to it |
|---|---|---|
| Amphetamines/methamphetamine | Stimulant drug class and metabolites | No. Different chemical structure, no published cross reactivity |
| Opioids | Prescription and illicit opioid metabolites | No. Not an opioid or related compound |
| Cannabinoids (THC) | THC metabolite | No. Not a cannabinoid |
| Benzodiazepines | Sedative class metabolites | No. Different structure and mechanism |
| Specimen validity checks | Creatinine, pH, specific gravity, adulterants | Not a known adulterant; no evidence it alters these markers |
Why an amino acid supplement does not appear on a drug test
Drug test panels are purpose built. Manufacturers and federal guidance choose target analytes based on misuse patterns, regulatory priorities, and documented cross reactivity research, not based on every compound found in food or tea. Because L-theanine is a dietary amino acid rather than a scheduled or commonly misused substance, no commercial drug test cup, dip card, or oral fluid device includes an antibody designed to detect it, and there is no reason it would trigger a positive on panels built for amphetamines, opioids, cannabinoids, cocaine metabolites, PCP, or benzodiazepines. Caffeine containing energy blends that also include L-theanine raise separate questions about caffeine itself, which is a different compound with its own, still limited, body of cross reactivity discussion; that question is addressed in a related post rather than here, since this article covers L-theanine specifically.
If someone takes an L-theanine supplement and later tests positive for an unrelated substance, the result should be treated the same way any unexpected result is treated: through confirmation testing and medical review officer follow up, not by assuming the supplement caused it. A nonnegative screening result is a preliminary immunoassay finding. Confirmation by gas chromatography mass spectrometry (GC/MS) or liquid chromatography tandem mass spectrometry (LC/MS/MS) identifies the specific molecule present at a specific concentration, which is a different and more specific method than the antibody based screen. If a laboratory confirms a result, a certified medical review officer contacts the individual to review prescriptions, over the counter products, and supplement use before the result is reported to the employer. L-theanine supplements are not a documented explanation the MRO process would expect to need, because no verified cross reactivity pathway exists for this substance, but any legitimate medication or prescription should still be disclosed to the MRO in that review.
What employers and employees should take away
Employers building or maintaining a drug free workplace program should rely on panels designed around documented drug classes and on SAMHSA and laboratory guidance rather than trying to anticipate every supplement on the market. Employees who use L-theanine, alone or in a calm focus or sleep blend, do not need to disclose it before a standard workplace screen on the theory that it will cause a positive result, since no credible evidence supports that outcome. If a product combines L-theanine with other active ingredients, such as caffeine, CBD, kratom, or an unlisted stimulant, it is the other ingredient, not the L-theanine, that would need separate evaluation, and reading the supplement facts panel before use is the simplest way to know what is actually being taken.
Organizations that manage their own collection process, including clinics, staffing agencies, and employer health programs, can review device options and current panel configurations through American Screening Corporation's wholesale portal at wholesale.americanscreeningcorp.com, and retail buyers can browse drug test cups or oral fluid drug tests to compare panel options.
For background on related supplements and on how unexpected results are handled, see Does Ashwagandha Show Up on a Drug Test? and The Medical Review Officer (MRO) Process Explained for Employers.
Frequently asked questions
Is L-theanine a controlled substance?
No. L-theanine is an amino acid found in tea and sold as an unscheduled dietary supplement. It is not regulated as a drug and is not listed on any federal controlled substances schedule.
Will L-theanine show up on a 5 panel or 10 panel drug test?
No standard workplace panel includes an antibody or confirmation method targeting L-theanine, because it is not a drug class those panels are designed to detect, and there is no published cross reactivity evidence linking it to the drug classes those panels do target.
Can L-theanine cause a false positive?
There is no credible published evidence of L-theanine causing a false positive on standard immunoassay drug screens. Any nonnegative result should go through laboratory confirmation and medical review officer evaluation rather than being attributed to a supplement without that review.
Does the FDA approve L-theanine supplements?
The FDA does not approve dietary supplement ingredients the way it approves prescription drugs. Some L-theanine preparations have gone through the FDA's GRAS notification process for use as a food ingredient, which is a food safety pathway, not a drug approval and not related to drug testing.
What should I do if I test positive while taking an L-theanine supplement?
Disclose any medications, prescriptions, or supplements to the medical review officer during the verification call for a confirmed nonnegative result. The MRO reviews that information along with the laboratory's confirmation testing before a final result is reported.
Is L-theanine the same as CBD or kratom?
No. L-theanine is an amino acid from tea leaves with no relationship to cannabinoids or to the alkaloids found in kratom. Products that combine L-theanine with other active ingredients should be evaluated based on those other ingredients.
This article is general information, not legal or medical advice. Employers and individuals should consult qualified legal counsel or a medical review officer for guidance specific to their situation.
